
Home » Whistleblower Suit Accusing Bayer of Defrauding DoD Allowed to Proceed
Whistleblower Suit Accusing Bayer of Defrauding DoD Allowed to Proceed
October 24, 2013
A federal appeals court Oct. 15 said a former Bayer employee will be allowed to proceed with a whistleblower lawsuit accusing the drugmaker of defrauding the Department of Defense (DoD) into buying mass quantities of its cholesterol drug Baycol.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
15Apr
-
21Apr
-
26Apr
-
06May